Experts’ views on developments in EGFR+ NSCLC from June 2021
8 June 2021

Experts’ views on developments in EGFR+ NSCLC from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe the novel treatment paradigms for patients with EGFR mutations with advanced NSCLC
  • Evaluate the impact of latest advances in the clinical landscape for NSCLC EGFR exon 20 insertion mutations

 

Co-chairs:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

more info...

EM-57446
Experts’ views on prostate cancer news from June 2021
8 June 2021

Experts’ views on prostate cancer news from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer from June 2021
  • Discuss how these new data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Karim Fizazi (France)
  • Oliver Sartor (USA) ...

more info...

EM-60950
Experts’ views on bladder cancer news from June 2021
11 June 2021

Experts’ views on bladder cancer news from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss new data in bladder cancer
  • Integrate new data into the current disease landscape

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)
more info...

EM-60952
Charting the landscape for EGFR-positive NSCLC
24 September 2021

Charting the landscape for EGFR-positive NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate developments in molecular testing for EGFRm+ NSCLC
  • Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
more info...

EM-60990
EGFR+ NSCLC in 2021: Key highlights of the year
15 December 2021

EGFR+ NSCLC in 2021: Key highlights of the year

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe key data on the diagnosis and management of patients with EGFR-positive NSCLC from 2021
  • Contextualise key learnings from 2021 into clinical practice through case study discussion and evaluation

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
more info...

EM-60991
New developments in diagnostics and therapeutics for EGFR+ NSCLC
7 April 2021 - 58 Minutes

New developments in diagnostics and therapeutics for EGFR+ NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate recent advances in the diagnosis and management for EGFR-positive NSCLC
  • Describe how new developments might be integrated into clinical practice

 

Co-chairs:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

Faculty:

  • Enriqueta Felip (Spain)
  • Albrecht Stenzinger (Germany)

 

more info...

EM-55209
ON DEMAND Webinar: Spotlight on emerging therapies for patients with EGFR-positive NSCLC
2 April 2021 - 90 Minutes

ON DEMAND Webinar: Spotlight on emerging therapies for patients with EGFR-positive NSCLC

Learning objective:         

After watching this webinar, participants should be able to:

  • Describe the novel paradigms for TKI resistant disease in advanced NSCLC patients with common EGFR mutations
  • Evaluate the unmet needs for advanced NSCLC patients with EGFR exon 20 insertions
  • Identify and review the latest advances of the emerging options in ...
more info...

EM-53390
Experts’ views on bladder cancer news from February 2021
17 February 2021 - 59 Minutes

Experts’ views on bladder cancer news from February 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss new data in bladder cancer
  • Integrate new data into the current disease landscape

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)
  • Petros Grivas (USA)
  • Shahrokh Shariat (Austria)
more info...

EM-50845
Experts’ views on prostate cancer news from February 2021
15 February 2021 - 61 Minutes

Experts’ views on prostate cancer news from February 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the recent data on prostate cancer from February
  • Discuss how these recent data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kim Chi (Canada)
  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Fred Saad (Canada)
more info...

EM-50843
ON DEMAND webinar: What the future holds for advanced NSCLC patients with resistance to EGFR TKIs
15 February 2021 - 58 Minutes

ON DEMAND webinar: What the future holds for advanced NSCLC patients with resistance to EGFR TKIs

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss the unmet needs for advanced NSCLC patients with EGFR Exon20 insertion mutations
  • Discuss the latest data on novel treatments in this patient group
  • Understand the novel management paradigms for TKI resistant disease in advanced NSCLC patients with EGFR mutations

 

Faculty:

  • Tetsuya ...

more info...

EM-52440
;